Hello everyone, I hope the new year is treating you well. My apologies on the long absence from the blog, it’s been way too long since I’ve written an update on the portfolio. This is the first post made on the site since September, so it feels great to get back in the saddle once again.
I keep hoping that I’ll find more time for writing on investments and my portfolio, but it’s becoming apparent that more limited time is my new reality. With a full-time job and three young kiddos at home, I’m finding that it’s not just the busyness of life that keeps increasing, but also the exhaustion at the end of the day from keeping up with it all. Maybe it has something to do with turning 40 in the fall; but those midnight writing sessions just don’t come as easy as they used to!
After taking a beating in 2016, it appears that the Healthcare Sector may be on the rebound. I have been taking advantage of the cheap prices by consistently adding to my positions over the last 6 months, with new positions and multiple buys made in Abbott Labs $ABT and CVS Health $CVS, along with adding to my positions in Omega Healthcare $OHI, and AbbVie Inc. $ABBV.
Here are the prices for those transactions, and how they have done so far.
On the surface, those numbers don’t look all that great, as the first three purchases made are still underweight. I was a bit early in jumping in on CVS Health Corp., and my first two buys remain under water. However, I made a third purchase following the big drop on earnings, and that has worked out well so far, as that buy is up nearly 11%.